Cardinal Health, Inc. vs Johnson & Johnson
CAH vs JNJ — side-by-side comparison from reported financials. CAH leads 7, JNJ leads 4 of 11 comparable metrics.
Cardinal Health, Inc.
CAH · Healthcare
$237.57-0.58%Solid
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | CAH | JNJ |
|---|---|---|
| Price | $237.57 | $261.79 |
| Market cap | $55.0B | $631B |
| Revenue (TTM) | $254B | $97.9B |
| Revenue growth | +7.4% | +5.6% |
| Net margin | 0.7% | 21.5% |
| Free cash flow | $4.53B | $22.2B |
| Net cash (debt) | ($5.14B) | ($27.8B) |
| 1-year price return | +51.1% | +37.0% |
| P/E | 32.1 | 29.9 |
| P/E vs own history (cheap-side %) | 26% | 16% |
| Dividend yield | 0.89% | 2.00% |
| Return on equity | 37% | 26% |
| Altman Z-score | 5.09 | — |
| CV checks passed | 11 of 11 | 10 of 11 |
| Employees | 63,900 | 140,800 |
Full résumé-style profiles: CAH CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.